2Seventy Bio Performance

TSVTDelisted Stock  USD 5.00  0.00  0.00%   
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and 2Seventy Bio are completely uncorrelated.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days 2Seventy Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, 2Seventy Bio is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
  

2Seventy Bio Relative Risk vs. Return Landscape

If you would invest  500.00  in 2Seventy Bio on September 27, 2025 and sell it today you would earn a total of  0.00  from holding 2Seventy Bio or generate 0.0% return on investment over 90 days. 2Seventy Bio is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than 2Seventy, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

2Seventy Bio Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for 2Seventy Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as 2Seventy Bio, and traders can use it to determine the average amount a 2Seventy Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
TSVT
Based on monthly moving average 2Seventy Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of 2Seventy Bio by adding 2Seventy Bio to a well-diversified portfolio.

2Seventy Bio Fundamentals Growth

2Seventy Stock prices reflect investors' perceptions of the future prospects and financial health of 2Seventy Bio, and 2Seventy Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on 2Seventy Stock performance.

About 2Seventy Bio Performance

Assessing 2Seventy Bio's fundamental ratios provides investors with valuable insights into 2Seventy Bio's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the 2Seventy Bio is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts. 2Seventy Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 437 people.

Things to note about 2Seventy Bio performance evaluation

Checking the ongoing alerts about 2Seventy Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for 2Seventy Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
2Seventy Bio is not yet fully synchronised with the market data
2Seventy Bio has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 37.86 M. Net Loss for the year was (57.25 M) with loss before overhead, payroll, taxes, and interest of (13.24 M).
2Seventy Bio currently holds about 357.93 M in cash with (85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 82.0% of the company shares are owned by institutional investors
Evaluating 2Seventy Bio's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate 2Seventy Bio's stock performance include:
  • Analyzing 2Seventy Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether 2Seventy Bio's stock is overvalued or undervalued compared to its peers.
  • Examining 2Seventy Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating 2Seventy Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of 2Seventy Bio's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of 2Seventy Bio's stock. These opinions can provide insight into 2Seventy Bio's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating 2Seventy Bio's stock performance is not an exact science, and many factors can impact 2Seventy Bio's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in 2Seventy Stock

If you are still planning to invest in 2Seventy Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the 2Seventy Bio's history and understand the potential risks before investing.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities